ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Communication Services / HAO / dividends
TNMG (53) FCDH (26) YDKG (48) INUV (26) ⌘ Pro Terminal →

Haoxi Health Technology Limited (Class A) (HAO) Dividend Safety Gauge & 10-Year DRIP Compounder

$1.96 +2.08% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.96

Haoxi Health Technology Limited (Class A) (HAO) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $1.2M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HAO Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HAO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Haoxi Health Technology Limited (Class A) (NASDAQ: HAO) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $1.96 (+2.08% 1D, market cap $1.2M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 7/20. Across 132 tracked Communication Services issuers, HAO ranks #101 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HAO compare to TNMG and FCDH in the Communication Services sector?
▼

Within the Communication Services sector (Advertising), HAO carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of —. By comparison, TNMG (TNL Mediagene) holds a D+ grade (53/100 RQD, P/E N/A, ROIC —, cap $3.0M) and FCDH (Forcendra Holding Limited (Class A)) posts a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $3.1M). Among the 5-stock peer group, HAO leads on earnings multiple (N/A) while YDKG leads on capital efficiency (-11.5% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HAO?
▼

Per HAO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001954594), Haoxi Health Technology Limited (Class A) generated $537.6K in revenue (-54.6% YoY), $3.9M in net income, and -$3.4M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Communication Services with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.96 (+0.18%)🧬 Disciplined Float (+0.16% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (36/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510036
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D
Cash (8)Whales (3)SEC (10)Macro (8)CEO (7)
Each axis scored 0–20
12M PRICE TARGET CONE-9.7% Base Target
$4570 Bull$2 Base$1 Bear
📬 FREE HAO RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HAO)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (36/100 Composite)
🔍 WHY HAO SCORES 36/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 92.8% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
44
Grade D$2.27-5.7% Next Q
Q2 (-2Q)
41
Grade D$2.14-25.2% Next Q
Q3 (-1Q)
39
Grade E$1.60+22.5% Next Q
Current
36
Grade D-$1.96-8.3% Hist 90D α
Trajectory: D (44) → D- (36)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a HAO Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While HAO currently carries a cautious 36/100 (D-) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Communication Services with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.63) and Max Pain ($2.06) forces dealer call-delta covering toward $4,569.60.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HAO• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HAO Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”
YES 36%NO 64%Trade / Inspect Odds →
CASH DIVIDEND + BUYBACK YIELD
1.8% Total Yield
0% Cash ($0.00/yr) + 1.8% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 • REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr
$10.6K
Yr 1
$11.1K
Yr 2
$11.7K
Yr 3
$12.4K
Yr 4
$13.1K
Yr 5
$13.8K
Yr 6
$14.5K
Yr 7
$15.3K
Yr 8
$16.2K
Yr 9
$17.1K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HAO)

  • ✓Walkthrough of HAO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
HAO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -99.89%▲ RESISTANCE BREAKOUT
2026-11-03O $2.04H $2.04L $1.92C $1.96VOL 37.9K
RES: $0.99SUP: $0.55SMA50: $2.63SMA200: $1,144.3
$3,196.9$2,330.9$1,464.9$598.8$-267.16RES $0.99SUP $0.55$1.962026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HAO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HAO Butterfly Map → + Track HAO →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -54.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HAO today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HAO. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HAO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HAO)

Communication Services Rank #101 of 132 ⚔️ TNMG vs HAO Full Matrix →

1. Head-to-Head Communication Services Peer Comparison (HAO vs. TNMG, FCDH, YDKG, INUV)

Industry: Advertising (23 Tracked Issuers)

Across 132 tracked Communication Services securities in the Roarable RQD universe, Haoxi Health Technology Limited (Class A) (HAO) ranks #101 by composite RQD confidence (36/100, grade D-) and #131 by equity capitalization ($1.2M). Within this direct 5-issuer industry benchmark cohort, HAO leads on earnings valuation at N/A trailing P/E, while YDKG leads on capital efficiency and profitability with -11.5% ROIC and -2.5% gross margin. TNMG currently holds the highest overall quantitative score in the immediate peer group at 53/100 (D+) compared with HAO at 36/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HAO ACTIVE
Haoxi Health Technology Limited (Class A)
D- 36/100 — 96.0% — +2.08% $1.2M Benchmark Subject
TNMG
TNL Mediagene
D+ 53/100 — — — +6.68% $3.0M /tnmg-vs-hao →
FCDH
Forcendra Holding Limited (Class A)
E 26/100 — 23.7% -35.0% -4.36% $3.1M /fcdh-vs-hao →
YDKG
Yueda Digital Holding Class A Ordinary Share
D 48/100 — -2.5% -11.5% -1.11% $5.0M /ydkg-vs-hao →
INUV
Inuvo Inc.
E 26/100 — 74.5% -35.0% +2.41% $6.8M /inuv-vs-hao →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001954594 ↗

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Haoxi Health Technology Limited (Class A) (HAO) reported GAAP revenue of $537.6K (-54.6% vs. FY2024 revenue of $1.2M , and -98.1% cumulative change since FY2023) , GAAP net income of $3.9M, operating cash flow of -$3.4M, and free cash flow of -$3.4M (-318.2% YoY). On the balance sheet, HAO closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-06-30 $537.6K $3.9M -$3.4M -$3.4M — —
FY2024 (FY) 2024-06-30 $1.2M $1.3M -$747.6K -$802.9K $22.1M —
FY2023 (FY) 2023-06-30 $28.2M $969.8K -$872.1K -$872.1K — —

3. HAO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HAO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Haoxi Health Technology Limited (Class A) (NASDAQ: HAO) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $1.96 (+2.08% 1D, market cap $1.2M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 7/20. Across 132 tracked Communication Services issuers, HAO ranks #101 in composite RQD confidence.

How does HAO compare to TNMG and FCDH in the Communication Services sector?

Within the Communication Services sector (Advertising), HAO carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of —. By comparison, TNMG (TNL Mediagene) holds a D+ grade (53/100 RQD, P/E N/A, ROIC —, cap $3.0M) and FCDH (Forcendra Holding Limited (Class A)) posts a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $3.1M). Among the 5-stock peer group, HAO leads on earnings multiple (N/A) while YDKG leads on capital efficiency (-11.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HAO?

Per HAO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001954594), Haoxi Health Technology Limited (Class A) generated $537.6K in revenue (-54.6% YoY), $3.9M in net income, and -$3.4M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Communication Services with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HAO trading relative to its 50-day, 200-day, and 52-week technical levels?

HAO last traded at $1.96 (+2.08% on volume of 9,277 shares), positioning the stock -25.48% below its 50-day simple moving average ($2.63) and -99.83% below its 200-day simple moving average ($1,144.32). Across its 52-week range of $1.60 to $4,352.00, HAO sits at the 0.0% percentile with a 14-day RSI of 35.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.72 to $2.20).

Direct Sub-Reports: HAO RQD Cockpit HAO 12M Forecast HAO Earnings & Move HAO Dividends & DRIP HAO Insiders & 13F HAO Whale Options HAO Profit Sankey HAO News & Why
ROARABLE RATING BRIEF • RQD 36/100 (D-) ✓ SEC XBRL & RQD VERIFIED

HAO — Haoxi Health Technology Limited (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-06-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Haoxi Health Technology Limited (Class A) (HAO) earns a live Roarable RQD composite score of 36/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $1.96 (+2.08% 1D, market capitalization $1.2M).

  • Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of —, gross margin of 96.0%, operating margin of -60.0%, and free cash flow yield of —.
  • Whale 13F & Options Flow (3/20) + Insider Conviction (7/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 3/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Haoxi Health Technology Limited (Class A) is a NASDAQ-listed issuer classified under the Communication Services sector and the Advertising industry,. Operating margin is reported at -60% and gross margin at 96% per the market data section.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Haoxi Health Technology Limited (Class A) (HAO) reported $537.6K in annual revenue (up from $1.2M in FY2024, -54.6% YoY) and $3.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($28.2M revenue, $969.8K net income) through FY2025, HAO scaled operating cash flow to -$3.4M and free cash flow to -$3.4M, backed by $0 in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 36/100): Established market leader in Communication Services with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $1.60 – $4,352.00 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream links are recorded, and no proprietary signals are provided. The graph classifies the sector as Communication Services and the industry as Advertising, but records no dependency relationships. A prospective investor should therefore treat second-order ripple effects as unmapped in the source data. Any sector-level sensitivity would have to be inferred from the RQD macro regime pillar (Beta of 1.0), which does not identify specific supplier or customer exposures.

  • Key Question #1: Can HAO sustain or expand its -60.0% operating margin and — ROIC against Advertising peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $537.6K and free cash flow of -$3.4M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is HAO's equity valuation to Communication Services capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

HAO Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Haoxi Health Technology Limited (Class A) (HAO) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HAO Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HAO Bull vs. Bear Conversation Board — What's Your Call at $1.96?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HAO 🐻 33% BEARISH CONVICTION
1. Pick Your Side on HAO:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $2.23 (+16.1%)
📌 Pinned Debate

Positive reported FY 2025 net income of $3.9M shows the income statement can diverge favorably from operating results.

Picked up a starter position in HAO in my $100K Virtual Cash book at $1.92. Positive reported FY 2025 net income of $3.9M shows the income statement can diverge favorably from operating results.. Trading inside a $1.60–$4352.00 52-week range with 0.0% FCF yield gives solid downside support if Advertising multiples expand this quarter.

RetailWhale_TX 🐂 BULL

Both sides have a point here — HAO's 10/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $1.63 (-15.1%)
Spot @ $1.92

Revenue fell from $28.2M in FY 2023 to $0.5M in FY 2025 while free cash flow stayed negative every year, and the RQD rating is 36 with

Revenue fell from $28.2M in FY 2023 to $0.5M in FY 2025 while free cash flow stayed negative every year, and the RQD rating is 36 with a D- grade.. Look at the math on HAO: paying current EV/EBITDA multiples for 0.0% ROIC and -60.0% operating margins leaves zero margin of safety if Advertising demand softens. I'd wait for a retest of $1.69 before getting long.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%